Search
  1. Home
  2. West Africa
  3. Mali

Government signs up for cheaper AIDS drugs

    ABIDJAN

    The Malian government has signed an agreement with four international pharmaceutical companies to drastically reduce the cost of drugs which suppress the growth of HIV, AFP reported.

    A treatment which used to cost some US $480 per patient each month will now cost between $60 and $110 monthly, Malian Health Minister Traore Fatoumata Nafo told reporters on Saturday. The companies that signed the deal are Boehringer-Ingelheim from Germany, GlaxoSmithKline from Britain and US firms, Merck and Bristol Myers Squibb.

    The South African government is currently engaged in a court battle with 39 pharmaceutical companies to facilitate access to cheaper medicine.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join